|
Volume 270,
Number 21,
Issue of May 26, pp. 12593-12600, 1995
©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
Impaired Insulin
Signaling in Skeletal Muscles from Transgenic Mice Expressing
Kinase-deficient Insulin Receptors
Pi-Yun
Chang
,
Laurie
J.
Goodyear
,
Heike
Benecke
,
Jeffrey S.
Markuns
,
David
E.
Moller
Transgenic mice which overexpress kinase-deficient human insulin
receptors in muscle were used to study the relationship between insulin
receptor tyrosine kinase and the in vivo activation of several
downstream signaling pathways. Intravenous insulin stimulated insulin
receptor tyrosine kinase activity by 7-fold in control muscle
versus 1.5-fold in muscle from transgenic mice. Similarly,
insulin failed to stimulate tyrosyl phosphorylation of receptor
-subunits or insulin receptor substrate 1 (IRS-1) in transgenic
muscle. Insulin substantially stimulated IRS-1-associated
phosphatidylinositol (PI) 3-kinase in control versus absent
stimulation in transgenic muscles. In contrast, insulin-like growth
factor 1 modestly stimulated PI 3-kinase in both control and transgenic
muscle. The effects of insulin to stimulate p42 mitogen-activated
protein kinase and c-fos mRNA expression were also markedly
impaired in transgenic muscle. Specific immunoprecipitation of human
receptors followed by measurement of residual insulin receptors
suggested the presence of hybrid mouse-human heterodimers. In contrast,
negligible hybrid formation involving insulin-like growth factor 1
receptors was evident. We conclude that (i) transgenic expression of
kinase-defective insulin receptors exerts dominant-negative effects at
the level of receptor autophosphorylation and kinase activation; (ii)
insulin receptor tyrosine kinase activity is required for in vivo insulin-stimulated IRS-1 phosphorylation, IRS-1-associated PI
3-kinase activation, phosphorylation of mitogen-activated protein
kinase, and c-fos gene induction in skeletal muscle; (iii)
hybrid receptor formation is likely to contribute to the in vivo dominant-negative effects of kinase-defective receptor expression.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
E. R. Duncan, P. A. Crossey, S. Walker, N. Anilkumar, L. Poston, G. Douglas, V. A. Ezzat, S. B. Wheatcroft, A. M. Shah, and M. I. Kearney
Effect of Endothelium-Specific Insulin Resistance on Endothelial Function In Vivo
Diabetes,
December 1, 2008;
57(12):
3307 - 3314.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. J. Murphy
Insulin-like growth factor-I: a treatment for type 2 diabetes revisited.
Endocrinology,
June 1, 2006;
147(6):
2616 - 2618.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Okamoto and D. Accili
In Vivo Mutagenesis of the Insulin Receptor
J. Biol. Chem.,
August 1, 2003;
278(31):
28359 - 28362.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Hribal, F. Oriente, and D. Accili
Mouse models of insulin resistance
Am J Physiol Endocrinol Metab,
May 1, 2002;
282(5):
E977 - E981.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Suryawan, H. V. Nguyen, J. A. Bush, and T. A. Davis
Developmental changes in the feeding-induced activation of the insulin-signaling pathway in neonatal pigs
Am J Physiol Endocrinol Metab,
November 1, 2001;
281(5):
E908 - E915.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Poretsky, N. A. Cataldo, Z. Rosenwaks, and L. C. Giudice
The Insulin-Related Ovarian Regulatory System in Health and Disease
Endocr. Rev.,
August 1, 1999;
20(4):
535 - 582.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Xie, A. J. Paterson, E. Chin, L. M. Nabell, and J. E. Kudlow
Targeted Expression of a Dominant Negative Epidermal Growth Factor Receptor in the Mammary Gland of Transgenic Mice Inhibits Pubertal Mammary Duct Development
Mol. Endocrinol.,
November 1, 1997;
11(12):
1766 - 1781.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
L. Gnudi, E. U. Frevert, K. L. Houseknecht, P. Erhardt, and B. B. Kahn
Adenovirus-Mediated Gene Transfer of Dominant Negative Rasasn17 in 3T3L1 Adipocytes Does Not Alter Insulin-Stimulated PI3-Kinase Activity or Glucose Transport
Mol. Endocrinol.,
January 1, 1997;
11(1):
67 - 76.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P.-Y. Chang, Y. Le Marchand-Brustel, L. A. Cheatham, and D. E. Moller
Insulin Stimulation of Mitogen-activated Protein Kinase, p90[IMAGE], and p70 S6 Kinase in Skeletal Muscle of Normal and Insulin-resistant Mice
J. Biol. Chem.,
December 15, 1995;
270(50):
29928 - 29935.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1995 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|